Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib

SIMPLE SUMMARY: Colorectal cancer is the third most common cancer type worldwide. Despite the advancements in pharmacological and surgical treatment approaches, the management of metastatic colon cancer patients carrying BRAFV600E mutation remains challenging due to poor efficacy of chemotherapy dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Car, Iris, Dittmann, Antje, Klobučar, Marko, Grbčić, Petra, Kraljević Pavelić, Sandra, Sedić, Mirela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136293/
https://www.ncbi.nlm.nih.gov/pubmed/37106808
http://dx.doi.org/10.3390/biology12040608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136293/
https://www.ncbi.nlm.nih.gov/pubmed/37106808
http://dx.doi.org/10.3390/biology12040608

Ejemplares similares